These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK; Kim JH; Kang H; Cho JS; Smego RA Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [TBL] [Abstract][Full Text] [Related]
23. Determinants of drug-resistant tuberculosis: analysis of 11 countries. Espinal MA; Laserson K; Camacho M; Fusheng Z; Kim SJ; Tlali RE; Smith I; Suarez P; Antunes ML; George AG; Martin-Casabona N; Simelane P; Weyer K; Binkin N; Raviglione MC Int J Tuberc Lung Dis; 2001 Oct; 5(10):887-93. PubMed ID: 11605880 [TBL] [Abstract][Full Text] [Related]
24. Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients. Dhingra VK; Rajpal S; Bhalla P; Yadav A; Jain SK; Hanif M J Commun Dis; 2003 Jun; 35(2):82-9. PubMed ID: 15562953 [TBL] [Abstract][Full Text] [Related]
25. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087 [TBL] [Abstract][Full Text] [Related]
26. Comparative study of antituberculous drug resistance among Mycobacterium tuberculosis isolates recovered at the American University of Beirut Medical Center: 1996-1998 vs 1994-1995. Araj GF; Itani LY; Kanj NA; Jamaleddine GW J Med Liban; 2000; 48(1):18-22. PubMed ID: 10881438 [TBL] [Abstract][Full Text] [Related]
27. [Epidemiology of the resistance of Mycobacterium tuberculosis to antituberculosis drugs at the main hospital in Dakar, Senegal. A 4-year retrospective study (2000-2003)]. Chevalier B; Margery J; Sane M; Camara P; Lefebvre N; Gueye M; Thiam M; Perrier-Gros-Claude JD; Simon F; Fabre M; Soler C; Herve V; Mbaye PS; Debonne JM Rev Pneumol Clin; 2010 Sep; 66(4):266-71. PubMed ID: 20933169 [TBL] [Abstract][Full Text] [Related]
28. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia. Sar B; Keo C; Leng C; Saman M; Min DC; Chan S; Monchy D; Sarthou JL Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):104-7. PubMed ID: 19323041 [TBL] [Abstract][Full Text] [Related]
29. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB. El-Sayed Zaki M; Goda T Tuberculosis (Edinb); 2007 Mar; 87(2):102-8. PubMed ID: 17035089 [TBL] [Abstract][Full Text] [Related]
30. Surveillance of Mycobacterium tuberculosis drug resistance in France, 1995-1997. AZAY Mycobacteria Study Group. Robert J; Trystram D; Truffot-Pernot C; Carbonnelle B; Grosset J Int J Tuberc Lung Dis; 2000 Jul; 4(7):665-72. PubMed ID: 10907770 [TBL] [Abstract][Full Text] [Related]
31. Drug resistance among Mycobacterium tuberculosis isolates in Lebanon. Hamze MM; Araj GF Int J Tuberc Lung Dis; 1997 Aug; 1(4):314-8. PubMed ID: 9432386 [TBL] [Abstract][Full Text] [Related]
32. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy. Mehta J; Keith R; Al Hasan M; Ryland B; Roy T Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201 [TBL] [Abstract][Full Text] [Related]
33. Mycobacterium resistance to antimycobacterial reagent. Aghandous R; Zouhdi M; Zizi M; Errami M; Idrissi L Therapie; 1999; 54(5):623-5. PubMed ID: 10667100 [TBL] [Abstract][Full Text] [Related]
34. National anti-tuberculosis drug resistance survey, 2002, in Myanmar. Ti T; Lwin T; Mar TT; Maung W; Noe P; Htun A; Kluge HH; Wright A; Aziz MA; Paramasivan CN Int J Tuberc Lung Dis; 2006 Oct; 10(10):1111-6. PubMed ID: 17044203 [TBL] [Abstract][Full Text] [Related]
35. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study]. Yoshiyama T; Ogata H; Ito K; Aono A; Wada M Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318 [TBL] [Abstract][Full Text] [Related]
36. A continuing survey of drug-resistant tuberculosis, New York City, April 1994. Fujiwara PI; Cook SV; Rutherford CM; Crawford JT; Glickman SE; Kreiswirth BN; Sachdev PS; Osahan SS; Ebrahimzadeh A; Frieden TR Arch Intern Med; 1997 Mar; 157(5):531-6. PubMed ID: 9066457 [TBL] [Abstract][Full Text] [Related]
37. [Primary resistance of Mycobacterium tuberculosis in 10 hospitals of the community of Castille and Leon. Group of Microbiologists from Castille and Leon]. Alberte Castiñeiras A; Pérez Pascual P Rev Clin Esp; 1999 Mar; 199(3):132-5. PubMed ID: 10230290 [TBL] [Abstract][Full Text] [Related]
38. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone]. Belianin II; Shmelev EI Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039 [TBL] [Abstract][Full Text] [Related]
39. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana. Kenyon TA; Mwasekaga MJ; Huebner R; Rumisha D; Binkin N; Maganu E Int J Tuberc Lung Dis; 1999 Jan; 3(1):4-11. PubMed ID: 10094163 [TBL] [Abstract][Full Text] [Related]
40. The resistance to major antituberculous drugs of Mycobacterium tuberculosis strains isolated from the respiratory system specimens of tuberculosis patients in Duzce, Turkey. Ozturk CE; Balbay OA; Kaya D; Ceyhan I; Bulut I; Sahin I Jpn J Infect Dis; 2005 Feb; 58(1):47-9. PubMed ID: 15728994 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]